Caudill Cortney 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Oct 6, 2025
Insider Transaction Report
Form 4
Caudill Cortney
SVP, CHIEF OPERATING OFFICER
Transactions
- Award
Option to Purchase Common Stock
2025-10-03+9,031→ 9,031 totalExercise: $68.98From: 2026-10-03Exp: 2035-10-03→ Common Stock (9,031 underlying) - Award
Restricted Stock Units
2025-10-03+3,625→ 3,625 totalExercise: $0.00From: 2026-10-03→ Common Stock (3,625 underlying)
Footnotes (2)
- [F1]This option vests one-fourth on such date and then 1/48th monthly thereafter.
- [F2]This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.